NEW YORK – GSK will roll out its anti-PD-1 therapy Jemperli (dostarlimab) for certain endometrial cancer patients and its PARP inhibitor Zejula (niraparib) for ovarian cancer patients in India.

Tailoring prevention to a person's metabolic profile, especially addressing insulin resistance and inflammation , shows ...

GlaxoSmithKline (GSK) on Monday announced its foray into the Indian oncology market with the launch of two precision ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

Here is our list of the 11 best cancer stocks to buy right now.

The cause of death of the beloved 'WKRP in Cincinnati' actress, who died on Aug. 3, has finally been confirmed.

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

The cause of death for actress Loni Anderson has been confirmed less than three weeks after she died at age 79. Anderson died ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

Actress Loni Anderson's cause of death revealed to be metastatic uterine leiomyosarcoma, according to a death certificate obtained by TMZ.

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...